Whole Blood Aggregation Assay is used for Aspirin and Plavix therapy
Concerned about the risk of thrombosis or bleeding with your
CAD patients? Chrono-log can provide
you with the ability to perform quick platelet function screening.
Monitor the
effects of anti-platelet drugs such as… 1. Clopidogrel [Plavix] – determining pharmacodynamic
or pharmacokinetic resistance 2. Aspirin – measuring extent of response to
therapy 3. GPIIb/IIIa receptor blockage - including
post-treatment platelet recovery…using a Whole Blood Impedance assay. In a study
published in 2005, it was concluded that: "The WB impedance assay should be
widely used in the clinical practice to identify subjects who are resistant to
aspirin and clopidogrel."
Chrono-log Corporation has been a leading manufacturer
of platelet function testing devices since the mid-1960’s, with systems
operating worldwide in Clinical and Research Laboratories. Whole Blood/Optical Lumi-Aggregation Systems improve detection of abnormal platelet function by
simultaneously
measuring platelet aggregation and dense granule secretion in a
physiologic whole blood environment or in the traditional plasma sample. Need to
monitor anti-platelet therapy AND detect platelet defects? The NEW and highly
versatile Model 700 combines the comprehensive diagnostic capability of Lumi-Aggregation
with rapid and simple Whole Blood screening in one easy-to-use system.
Chrono-log also offers a complete line of Platelet Aggregometers and Reagents to diagnose specific platelet disorders. To obtain free reprint articles on how Chrono-log Whole Blood Aggregometers can provide you with the ability to perform quick platelet function screen to monitor the effectiveness of aspirin and other anti-platelet drugs, visit our ABSTRACT page.
© 2006 Chrono-log Corporation